Rothblatt Martine A

Chairperson &CEO | Director

2 companies

Insider Signal Score

Good

Trades Analyzed

303

12M Win Rate

53.6%

Avg 3M Return

-6.6%

Avg 12M Return

-1.6%

Rothblatt Martine A is a Chairperson &CEO at UNITED THERAPEUTICS Corp with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 101 sells.

Estimated insider holdings value: $23.5M based on current market prices.

Holdings by Company

UTHR6d ago

Current Shares43.6K

Value$23.39M

Net Activity-333,069

Bought: 0Sold: 333.1K

BETAJun 11, 2026

Current Shares8.2K

Value$132.2K

Net Activity0

Bought: 0Sold: 0

Transaction History

Showing 10 filings (page 6)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jun 21, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	7,200	$311.44	$2,242,388.76	-24.9%	+11.2%	-8.0%
Jun 18, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	7,495	$298.83	$2,239,704.11	-18.3%	+12.7%	-4.7%
Jun 14, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	3,600	$287.22	$1,033,984.24	-52.4%	+18.4%	-1.6%
Jun 13, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	3,600	$285.48	$1,027,715.79	-16.3%	+20.4%	-1.5%
Jun 12, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	7,200	$278.45	$2,004,850.66	-32.9%	+21.5%	+1.5%
Jun 10, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	7,200	$275.54	$1,983,862.05	-31.1%	+26.7%	+2.2%
Jun 6, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	7,200	$277.24	$1,996,118.62	-25.9%	+27.8%	+17.9%
Jun 4, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	7,200	$275.01	$1,980,099.84	-34.5%	+29.0%	+18.6%
May 31, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	7,200	$271.29	$1,953,289.46	-29.4%	+30.9%	+15.9%
May 29, 2024	UTHR United Therapeutics Corp	Director	Sale+OE	7,200	$268.09	$1,930,282.98	-36.7%	+30.4%	+19.7%

← PrevPage 6Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC